382 filings
Page 4 of 20
8-K
t3jtm6
17 Jan 19
Spectrum will receive $160 million in an upfront cash payment and up to $140 million in regulatory and sales-based milestones
7:57am
8-K
m87s41ayi0y 6b
7 Jan 19
Regulation FD Disclosure
9:01am
8-K
aoj1sc6uw 7ct
19 Dec 18
Spectrum Pharmaceuticals Provides Poziotinib Update
4:02pm
8-K
kzkgfkf 8h7wjn2r2
13 Nov 18
Departure of Directors or Certain Officers
7:00am
8-K
lgvmbi9yso93xz
8 Nov 18
Spectrum Pharmaceuticals Reports Third Quarter 2018 Pipeline Update and Financial Results
4:03pm
8-K
1m3wq6gkjf flc
9 Aug 18
Spectrum Pharmaceuticals Reports Second Quarter 2018 Financial Results and Pipeline Update
4:05pm
8-K
6ofu5 zcqezy
18 Jun 18
Departure of Directors or Certain Officers
4:10pm
8-K
j2rycdl2hc70
3 May 18
Spectrum Pharmaceuticals Reports First Quarter 2018 Financial Results and Pipeline Update
4:03pm
8-K
nk8t2ivsl76d27lkhtt
16 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
3h3a2shdwtr08j7ezrl4
29 Mar 18
Entry into a Material Definitive Agreement
12:00am
8-K
ncnid26
20 Mar 18
Other Events
12:00am
8-K
ei0548k c7dp7ow
6 Mar 18
Spectrum Pharmaceuticals Reports Fourth Quarter 2017 and Full Year 2017 Financial Results and Pipeline Update
12:00am
8-K
hcwdflje
27 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
tj6tleqdu2a2scm8
19 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
r4lddks
8 Jan 18
Spectrum Pharmaceuticals Joseph Turgeon President and Chief Executive Officer January 2018 Investor Presentation
12:00am
8-K
lckx4 5o3vd
21 Dec 17
Regulation FD Disclosure
12:00am
8-K
ens 16wufb
18 Dec 17
Spectrum Pharmaceuticals Announces Leadership Changes
12:00am
8-K
xcsj5 cvt
2 Nov 17
Spectrum Pharmaceuticals Reports Third Quarter 2017 Financial Results and Pipeline Update
12:00am
8-K
1z2bmqbmf5nzjaax
18 Oct 17
Regulation FD Disclosure
12:00am
8-K
pcy7aov8f738p0yf
13 Oct 17
Entry into a Material Definitive Agreement
12:00am